Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
13 hedge funds and large institutions have $33M invested in Zealand Pharma A/S American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
8% more funds holding
Funds holding: 12 → 13 (+1)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
33% less capital invested
Capital invested by funds: $49.2M → $33M (-$16.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$332K |
| 2 |
AIC
AWM Investment Company
New York
|
+$262K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$229K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$20.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.42M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.37M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$114K |
| 4 |
JP Morgan Chase
New York
|
-$64.2K |
| 5 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$21K |
ZEAL Hedge Fund Activity: Q4 2018 in Review
13 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q4 2018, worth a combined $33M — down 33% from $49.2M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ZEAL positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $332K. The largest seller was Millennium Management, exiting entirely with an estimated $1.42M sold.
- 13 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q4 2018, up from 12 in Q3 2018.
- Funds reported $33M of Zealand Pharma A/S American Depositary Shares stock for Q4 2018, down 33% quarter-over-quarter.
- 3 funds opened new Zealand Pharma A/S American Depositary Shares positions in Q4 2018 and 2 closed out, a net change of +1 holder.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q4 2018 was Jane Street, an estimated $332K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q4 2018 was Millennium Management, an estimated $1.42M sold.
Based on aggregated 13F filings for Q4 2018.